Riskpilot← Back to searchSign inGet full accessHeartsave Scandinavia AB
ABBankruptOrg 5591771471Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20181 employees
Revenue 2020
SEK 1,4M
+29% vs 2019
EBITDA margin
-6.7%
-800% vs 2019
Equity ratio
10.7%
Financial strength
Net profit 2020
SEK -89K
-790% vs 2019
| Revenue | SEK 1,4M | +29% |
| EBITDA | SEK -90K | -800% |
| Net profit | SEK -89K | -790% |
| Total assets | SEK 466K | -8% |
| Equity | SEK 50K | +25% |
| Employees | 1 | — |
Legal name
Heartsave Scandinavia AB
Org number
5591771471
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
26 oktober 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsenStyrelsen ska bestå av 1 styrelseledamot och 1 styrelsesuppleant.
Company purpose
Företaget ska bedriva köp och försäljning av hjärtstartare samt tillbehör till dessa, och därmed förenlig verksamhet. Företaget ska även bedriva utbildning inom hjärtlungräddning (HLR), samt därmed förenlig verksamhet. Företaget skall även bedriva köp, försäljning och förvaltning av fast egendom, samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 |
|---|---|---|
| Revenue | 1 047 | 1 352 |
| Staff expenses | — | — |
| EBITDA | −10 | −90 |
| Depreciation & amort. | −0 | −0 |
| EBIT | −10 | −90 |
| Net financials | — | — |
| Profit before tax | −10 | −89 |
| Tax | −0 | −0 |
| Net profit | −10 | −89 |
| Item | 2019 | 2020 |
|---|---|---|
| Total assets | 505 | 466 |
| Equity | 40 | 50 |
| Long-term debt | 0 | 0 |
| Short-term debt | 465 | 416 |
| Total debt | 465 | 416 |
EBITDA margin
-6.7%
This company
15.8%
Market median
-142% vs market
20192020
Equity ratio
10.7%
This company
38.2%
Market median
-72% vs market
20192020
Return on equity
-178.0%
This company
18.4%
Market median
-1067% vs market
20192020
Net profit margin
-6.6%
This company
8.1%
Market median
-181% vs market
20192020
Asset turnover
2.90×
This company
1.12×
Market median
+159% vs market
20192020
Debt / equity
8.32×
This company
0.62×
Market median
-1242% vs market
20192020
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-10-01 – 2019-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2022 | |
| Former (3) | ||
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Heartsave Scandinavia AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Sjunne Öberg | Deputy Board Member | 0 companies |
| Bo Richard Joakim Brezén | Deputy Board Member | 0 companies |
| Per Gunnar Andersson | Deputy Board Member | 0 companies |
| Dick Robert Wettergren | Board of Directors | 0 companies |